Stable Glaucoma Service for the London Borough of Ealing and Hounslow
A Contract Award Notice
by NHS NORTH WEST LONDON INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £756K
- Sector
- HEALTH
- Published
- 10 Jul 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London
2 buyers
1 supplier
- Evolutio Care Innovations Henley on Thames
Description
Ongoing monitoring and management of glaucoma patients for the London Boroughs of Ealing and Hounslow
Total Quantity or Scope
- This service shall be for the provision of ongoing monitoring and consultant led care for patients with a known diagnosis of glaucoma- The initial contract (a direct award under ICFA (Increasing Capacity Framework Assessment)) was for a one-year duration from 01 June 2023 to 31 May 2024. There is a need to develop a new contract to replace existing contract for the ongoing provision of this service (the proposed contracting arrangements are not changing considerably from the existing contract).- NHS NWL ICB intend to award a contract to the existing provider following Direct Award Process C- The lifetime value of the contract is £756,000- The intention is to award a new contract for one year with the option to extend for an additional one year to the existing provider. A key factor in making this recommendation is continuity of care for patients
Award Detail
1 | Evolutio Care Innovations (Henley on Thames)
|
Award Criteria
PRICE | _ |
CPV Codes
- 85100000 - Health services
- 85121281 - Ophthalmologist services
Indicators
- Award on basis of price.
Legal Justification
An intention to award has been made following PSR Direct Award Process C.
Other Information
Award criteria (II.2.5) - the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard taking into account the key criteria and applying the basic selection criteria - This is a Provider Selection Regime (PSR) intention to award. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. - A Standstill Period is now in force pursuant to Regulations 12 and 14(3) of the PSR Regulations 2023; this period will end at midnight on 22 July 2024 and NHS North West London ICB will not enter into a contract pursuant to the award to the provider under direct award process C before this date.- Representations by providers must be made to decision-makers by midnight on 22 July 2024 (8 working days following publication of this intention to award notice). Should providers wish to make a representation please submit to helen.hewitt11@nhs.net. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. - The relevant authority's governance/decision-making panel are making the award decision- The relevant authority has taken into account the 5 Key Criteria and applied the basic selection criteria. The rationale for the relative importance of the Key Criteria is to ensure service continuity will be maintained for this group of patients through a service which is clinically effective, safe and timely. Enhanced patient experience as patients would not be moved around to yet another provider within 12 month period. The rationale for choosing the provider is that there is confidence that the provider is likely to satisfy future performance against the new contract at a cost effective price against the Key Criteria (service model, clinical governance, service innovation, monitoring the quality of the service provision, value, reduce health inequalities, improving access, service sustainability, social value and good practices identified). - There are no declared or potential conflicts of interest of individuals making the decision
Reference
- FTS 021074-2024